title: Interstitial lung disease associated with docetaxel in a patient treated for breast cancer - a case report.
abstract: Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibits normal interphase and mitotic cellular function, causing cell death. Docetaxel is indicated for the treatment of breast, lung and prostate cancers, head and neck cancer and gastric adenocarcinoma. Interstitial pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced interstitial lung disease (ILD) in a patient with breast cancer.
authors.affiliation: XI Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland. mpankowska@hotmail.com.
authors.forename: Monika
authors.initials: M
authors.lastname: Pankowska-Supryn
authors.forename: Monika
authors.initials: M
authors.lastname: Załęska
authors.forename: Barbara
authors.initials: B
authors.lastname: Roszkowska-Śliż
authors.forename: Kazimierz
authors.initials: K
authors.lastname: Roszkowski-Śliż
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy; D008875:Middle Aged; D043823:Taxoids / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel; D004317:Doxorubicin; D003520:Cyclophosphamide
keywords: breast cancer; docetaxel; interstitial lung disease